A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma

NCT02528643 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
165
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators